Across TCGA pan-cancer cohorts, TCP11X2 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated TCP11X2 data layer compared with 16 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher TCP11X2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TCP11X2 expression acts as an unfavorable survival marker.

COAD are the cancer types where TCP11X2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	III,IV	0.056	0.781	<.001	22	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: TCP11X2 tumor-vs-normal RNA expression · all TCP11X2 data types